Inovio Pharmaceuticals In...

1.84
-0.14 (-7.07%)
At close: Mar 03, 2025, 3:59 PM
1.84
-0.27%
After-hours: Mar 03, 2025, 05:29 PM EST

Inovio Pharmaceuticals Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99
Cash & Equivalents 14.31M 46.33M 71.14M 250.73M 22.2M 23.69M 23.79M 19.14M 57.63M 40.54M 33.72M 5.65M 17.35M 20M 30.3M 14.12M 10.25M 8.32M 17.17M 17.89M 13.46M 875.44K 1.81M 3.72M 9.74M
Short-Term Investments 130.98M 206.67M 330.17M 160.91M 67.34M 57.54M 103.64M 85.63M 105.36M 53.08M 18.91M 8.03M 12.86M 1.85M 13.54M n/a 17M 14.7M n/a n/a n/a n/a n/a 2.81M n/a
Long-Term Investments 2.78M 2.01M 3.91M 4.89M 6.32M 9.41M 11.39M 19.83M 19.99M 12.34M 9.66M 10.7M 9.07M 11.36M 12.33M 9.17M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 605.32K 684.04K 1.43M 25.96M 2.67M 2.67M 2.64M 2.11M 676.8K 1.02M 1.22M 501.8K 408.32K 259.13K 305.55K 167.25K 282K 132K n/a n/a 2.3M n/a 2.38M 2.33M 33.46K
Receivables 2.41M 11.74M 8.03M 19.06M 2.03M 4.05M 6.49M 16.57M 7.33M 2.8M 3.3M 866.67K 506.31K 105.04K 318.06K 671.19K 1.14M 326.07K 284.17K 424.16K 175K 75.59K 940.33K 903.53K 1.12M
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 847.91K 756.54K 611.64K
Other Current Assets 5.41M 50.51M 39.1M 40.46M 2.63M 2.53M 4.45M 3.26M 1.53M 2.52M 2.76M 1.42M 1.19M 927.41K 409.85K 477.29K 613.66K 1.12M 870.17K 124.72K 116.53K 1.75M 6.33K 61.4K 139.42K
Total Current Assets 153.11M 315.24M 448.44M 471.17M 94.2M 87.81M 138.36M 124.6M 171.85M 98.95M 58.68M 15.97M 31.91M 22.88M 44.57M 15.26M 29M 24.47M 18.32M 18.44M 13.75M 2.7M 3.61M 8.25M 11.61M
Property-Plant & Equipment 14.45M 17.96M 29.02M 24.09M 26.56M 15.95M 18.32M 9.03M 7.31M 4.58M 2.89M 363.02K 295.79K 276.8K 343.46K 353.81K 401.73K 390.79K 375.61K 155.25K 175.9K 295.32K 648.18K 904.03K 1.01M
Goodwill & Intangibles n/a 12.64M 13.14M 13.66M 14.21M 15.27M 16.52M 18.14M 14.02M 14.89M 15.83M 17.6M 19.42M 21.29M 23.08M 14.03M 10.09M 10.95M 10.28M 2.36M n/a 2.43M n/a n/a 1.35M
Total Long-Term Assets 17.84M 33.29M 47.5M 68.6M 49.75M 43.3M 48.88M 49.11M 41.99M 32.84M 29.6M 29.17M 29.2M 33.19M 36.06M 23.72M 10.77M 11.48M 10.66M 2.51M 2.48M 2.72M 3.03M 3.24M 2.4M
Total Assets 170.95M 348.53M 495.94M 539.77M 143.95M 131.11M 187.24M 173.71M 213.84M 131.79M 88.29M 45.14M 61.11M 56.07M 80.63M 38.99M 39.78M 35.95M 28.98M 20.95M 16.23M 5.42M 6.63M 11.49M 14.01M
Account Payables 4.65M 21.08M 27.97M 1.47M 7.65M 11.02M 8.49M 6.99M 4.46M 2.03M 2.39M 1.04M 1.16M n/a 1.57M 377.33K 1.81M 2.01M 1.86M 2.16M 827.65K n/a 1.46M 1.39M 1.78M
Deferred Revenue n/a n/a 21.63K 46.63K 124.13K 257.15K 1.35M 15.17M 13.95M 3.58M 2.01M 741.93K 468.04K 795.9K 270.33K 523.54K 973.43K 633.73K 1.21M 1.05M n/a 202.65K 115.02K 50.03K n/a
Short-Term Debt 19.18M 2.8M 2.6M 2.33M 2.07M n/a n/a n/a n/a n/a n/a n/a n/a n/a 12.11M 12.11M n/a n/a n/a n/a 331.16K 20.64K 27.48K 68.93K 53.1K
Other Current Liabilities 18.74M 72.98M 35.14M 37.86M 22.14M 24.02M 25.56M 21.66M 13.05M 8.47M 24.57M 6.59M 9.41M 5.64M 5.4M 1.7M 573.77K 4.22M 1.06M 2.2M n/a 1.43M n/a n/a 268.67K
Total Current Liabilities 42.57M 96.87M 65.74M 41.71M 31.99M 35.3M 35.41M 43.82M 31.47M 14.09M 28.97M 8.38M 11.04M 6.44M 19.35M 14.71M 3.35M 6.86M 4.14M 5.4M 1.16M 1.66M 1.61M 1.51M 2.11M
Long-Term Debt 11.03M 29.27M 30.42M 36.72M 97.43M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 20.64K 48.53K 65.29K
Other Long-Term Liabilities n/a n/a 14.83K 95.16K 8.99M 8.61M 9.1M 5.93M 5.49M 4.65M 3.01M 65.08K 80.88K 67.11K 11.34K 14.9K 4.44M 4.57M 296.08K n/a 22.54K 35.85K 44.88K 34.9K 9.97K
Total Long-Term Liabilities 11.03M 29.3M 30.53M 36.93M 106.56M 8.78M 9.35M 6.51M 6.44M 6.16M 6.42M 1.9M 2.2M 2.53M 93.93K 5.17M 5.39M 5.59M 1.37M n/a 22.54K 35.85K 65.52K 83.43K 75.26K
Total Liabilities 53.6M 126.17M 96.27M 78.63M 138.55M 44.08M 44.75M 50.33M 37.91M 20.25M 35.38M 10.28M 13.24M 8.97M 19.44M 19.88M 8.74M 12.45M 5.51M 5.4M 1.18M 1.69M 1.67M 1.6M 2.18M
Total Debt 30.21M 32.07M 33.02M 39.05M 99.51M n/a n/a n/a n/a n/a n/a n/a n/a n/a 12.11M 12.11M n/a n/a n/a n/a 331.16K 20.64K 48.12K 117.46K 118.38K
Common Stock 22.79K 21.09K 217.38K 186.85K 101.36K 97.23K 90.36K 74.06K 72.22K 60.74K 52.58K 144.31K 134.97K 105.04K 102.75K 44.02K 43.81K 35.64K 29.47K 18.42K 63.68K 50.4K 33.76K 33.76K 30.49M
Retained Earnings -1.62B -1.49B -1.21B -906.2M -739.79M -620.43M -523.36M -434.84M -361.1M -331.91M -295.79M -229.76M -210.09M -194.84M -177.22M -152.81M -139.85M -128.62M -114.27M -87.91M -76.2M -53.33M -47.36M -41M -29.6M
Comprehensive Income -662.6K -698.74K -282.24K -256.15K 472.61K -528.87K -117K 1.33M 2.71M -251.39K -76.36K 73.36K 35.39K 2.85K 105.8K 6.16K 107.53K -48.98K -30.3K n/a n/a -102.24K 1.17M -100.09K 10.9M
Shareholders Equity 117.35M 222.36M 399.67M 461.14M 3.44M 86.94M 142.39M 123.28M 175.69M 111.23M 52.46M 34.35M 47.31M 46.5M 60.56M 19.11M 31.03M 18.15M 23.47M 15.55M 15.05M 3.73M 4.96M 9.89M 11.83M
Total Investments 133.76M 208.68M 334.08M 165.81M 73.65M 66.94M 115.03M 105.46M 125.34M 65.42M 28.57M 18.74M 21.93M 13.21M 25.87M 9.17M 17M 14.7M n/a n/a n/a n/a n/a 2.81M n/a